BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14066965)

  • 1. MULTINUCLEARITY OF OSTEOCLASTS.
    SCHMIDT AJ
    Nature; 1963 Sep; 199():1113-4. PubMed ID: 14066965
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.
    Hattersley G; Chambers TJ
    Endocrinology; 1989 Apr; 124(4):1689-96. PubMed ID: 2924719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.
    Hocking LJ; Mellis DJ; McCabe PS; Helfrich MH; Rogers MJ
    Biochem Biophys Res Commun; 2010 Nov; 402(3):543-8. PubMed ID: 20971078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
    Mangashetti LS; Khapli SM; Wani MR
    J Immunol; 2005 Jul; 175(2):917-25. PubMed ID: 16002690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
    Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
    Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic demonstration of in vitro fusion of blood monocytes with osteoclasts.
    Zambonin Zallone A; Teti A
    Basic Appl Histochem; 1985; 29(1):45-8. PubMed ID: 4004718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts.
    ten Harkel B; Schoenmaker T; Picavet DI; Davison NL; de Vries TJ; Everts V
    PLoS One; 2015; 10(10):e0139564. PubMed ID: 26426806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORIGIN OF OSTEOCLASTS FROM THE FUSION OF PHAGOCYTES.
    JEE WS; NOLAN PD
    Nature; 1963 Oct; 200():225-6. PubMed ID: 14081054
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection and characterization of apoptosis in osteoclasts in vitro.
    Kameda T; Ishikawa H; Tsutsui T
    Biochem Biophys Res Commun; 1995 Feb; 207(2):753-60. PubMed ID: 7864869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?
    Andersen TL; Boissy P; Sondergaard TE; Kupisiewicz K; Plesner T; Rasmussen T; Haaber J; Kølvraa S; Delaissé JM
    J Pathol; 2007 Jan; 211(1):10-7. PubMed ID: 17083146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ; Oreffo RO; Mayor K; Mundy GR
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of nuclei in imprints of feline osteoclasts.
    Addison WC
    J Anat; 1979 Aug; 129(Pt 1):63-8. PubMed ID: 511772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of osteoclasts on calvaria of normal and osteopetrotic (mi/mi) mice by vital staining with acridine orange.
    Green PM; Marshall MJ; Nisbet NW
    Br J Exp Pathol; 1986 Feb; 67(1):85-93. PubMed ID: 2418863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ultrastructural analyses of rabbit osteoclasts. The effect of in vivo treatment with sodium salicylate.
    Kusakabe A; Francis MJ
    Nihon Seikeigeka Gakkai Zasshi; 1984 Mar; 58(3):349-60. PubMed ID: 6470542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [STUDIES ON THE CULTIVATION OF OSTEOCLASTS IN TISSUE CULTURE AND IN DIFFUSION CHAMBERS].
    VOGT H
    Pathol Microbiol (Basel); 1964; 27():42-53. PubMed ID: 14107355
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of alendronate on the expression of important cell factors in osteoclasts.
    Zhang Q; Liu M; Zhou Y; Liu W; Shen J; Shen Y; Liu L
    Mol Med Rep; 2013 Oct; 8(4):1195-203. PubMed ID: 23942871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear anomalies in osteoclasts in Paget's bone disease].
    Rebel A; Malkani K; Basle M
    Nouv Presse Med; 1974 May; 3(20):1299-301. PubMed ID: 4843079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of calcitonin on osteoclasts in Paget's bone disease during long term treatment (author's transl)].
    Rebel A; Basle M; Minard MF; Malkani K
    Pathol Biol (Paris); 1977 Nov; 25(9):611-6. PubMed ID: 202910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear inclusions in osteoclasts in Paget's bone disease.
    Rebel A; Malkani K; Baslé M; Bregeon C
    Calcif Tissue Res; 1976 Aug; 21 Suppl():113-6. PubMed ID: 182330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.